Reuters
Andrei Samokhin wrote, in “Vzglyad”, about the advantage of the Russian vaccine against the Corona virus, which the West recently recognized.
The article reads: Published by one of the most influential medical journals in the world – the British-Dutch edition of The Lancet– Tuesday, the results of the third phase of clinical trials of the Russian vaccine against the Corona virus.Sputnik VOn the example of more than 20 thousand volunteers, it was found that the Russian medicine is made of high quality. It does not cause dangerous side effects and builds strong immunity. Sputnik V The vaccine is 91.6% effective.
In practice, the results were evaluated by the European Office of the World Health Organization. On Wednesday, French President Emmanuel Macron authorized the use of Sputnik V, In his country. Earlier, German Chancellor Angela Merkel announced, in a conversation with Vladimir Putin, her willingness to cooperate in the production of the Russian vaccine and its use on the territory of the European Union.
Anatoly Suslov, director of the Laboratory for Immunomodulators and Effects at the Gamalia Institute, explained that “the publication in The Lancet“ paved the way for the licensing of the Sputnik V vaccine and its recognition in Europe. ”At the same time, he pointed out that the entry of the Russian vaccine to the international market is a matter related to Intense political and economic competition, more than about science.
He said, “We can definitely say that the Pfizer vaccine, compared to Sputnik, is very risky.” Pfizer is now being tested in the process of using it, directly on its shots. Problems may increase with its use. What is important is that if political and economic pressure on Sputnik suddenly weakens and the European Union needs millions of doses, then the situation will be in our favor. The post in The Lancet breaks the stereotype that “all things are wrong with the Russians”.
The Wall Street Journal noted that “Sputnik’s effectiveness is recognized V It means Putin’s victory in the global vaccine race, and constitutes an acknowledgment of the capabilities of Russian science and medicine, and refutes some of the criticisms that Moscow faced for the acceleration of vaccine development and the lack of published test data.
The article expresses only the opinion of the newspaper or writer